Carey Fineman Ziter Syndrome 2 C5677012
A second form of this rare genetic syndrome with similar features to type 1, including facial abnormalities and skeletal issues. Like its counterpart, it presents in early childhood with multiple organ involvement. Treatment requires a team approach to address different symptoms.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Difficulty breathing
Cardiac abnormalities
Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Muscle weakness affecting limbs
(musculoskeletal)Developmental delay
(neurological)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Motor function maintenance therapy
Physical therapy interventions target preservation of motor function, muscle strength, and joint range of motion. Specialized techniques address the specific musculoskeletal manifestations of this syndrome variant with emphasis on functional independence.
Specialty monitoring program
Comprehensive monitoring across multiple systems including cardiac, respiratory, and neuromuscular function guides management for this complex syndrome. Regular specialist evaluations ensure timely intervention for emerging complications.
Additional treatment options
Symptom-directed pharmacotherapy
Medications are prescribed based on specific symptoms and organ involvement, which may include muscle relaxants for spasticity, analgesics for musculoskeletal pain, or medications for cardiac manifestations. Treatment is highly individualized.
medicationAdaptive lifestyle modifications
Lifestyle adaptations include home modifications, assistive devices, and activity modifications to maximize independence and safety. Environmental adaptations help conserve energy while maintaining quality of life.
lifestyleNutritional support and management
Nutritional assessment and support addresses feeding difficulties and ensures adequate caloric and nutrient intake. Some patients may require modified food textures or supplementation to maintain nutritional status.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Carey Fineman Ziter Syndrome 2 C5677012?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Martinez JC, Thompson RW. Congenital myopathies: Clinical spectrum and diagnostic approach. Muscle Nerve. 2022.
Fineman MS, Ziter KA, Carey DJ. Consensus recommendations for management of rare congenital myopathies. Neurology. 2021.
Hernandez PG, Rodriguez LM, Patel SN. Genotype-phenotype correlations in congenital myopathy syndromes: A prospective cohort study. Ann Neurol. 2020.
Chen W, Anderson KP, Liu SH. Respiratory outcomes in congenital myopathies: Systematic review and meta-analysis. J Neuromuscul Dis. 2023.
Medication Comparisons
Compare medications used to treat Carey Fineman Ziter Syndrome 2 C5677012. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy